Follow us

  • X
  • Youtube

News Release

Release
GNI Group Receives Manufacture Approval for F647 from China FDA for First Idiopathic Pulmonary Fibrosis Drug in China
Release
（Amendment）GNI Group Receives Manufacture Approval for F647 from China FDA for First Idiopathic Pulmonary Fibrosis Drug in China
Release
Notice for Exercise of the 37th Round of Stock Options in December, 2013
Release
Notice for Large Volume Exercise of the 37th Round of Stock Option